Hyperlipidemia under treatment with proteinase inhibitors

Infection

Volumn 27, Issue 2, 1999, Pages 77-81

  Segerer, S ^a,b   Bogner, J R ^a   Walli, R ^a   Loch, O ^a   Goebel, F D ^a  

^a Dipl Stat O Loch   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; INDINAVIR; LIPID; NELFINAVIR; NUCLEOSIDE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033040212     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02560501     Document Type: Article

References (12)

1. Carpenter, C. C., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., Volherding, P. A.: Antiretroviral therapy for HIV infection in 1996. Updated recommendations of the International AIDS Society, USA. JAMA 277 (1997) 1962-1969.
2. Lipsky, J. J.: Antiretroviral drugs for AIDS. Lancet 348 (1996) 800-803.
3. Gulick, R. M., Mellors, J. W., Havlir, D., Eron, J. J., Gonzalez, C., McMahon, D., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A., Emini, A., Chodakewitz, A.: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337 (1997) 734-739.
4. Walli, R., Demant, T., Goebel, F. D.: Impaired glucose tolerance in HIV-infected patients treated with protease inhibitors is caused by peripheral insulin resistance. Ann. Intern. Med. 129 (1998) 837-838.
5. Walli, R., Herfort, O., Michl, G. M., Demant, T., Jäger, H., Dieterlec, C., Bogner, J. R., Landgraf, R., Goebel, F. D.: Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1 infected patients. AIDS 12 (1998) F167-F173.
6. Viraben, R., Aqulina, C.: Indinavir-associated lipodystrophy. AIDS 12 (1998) F37-F39.
7. Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., Cooper, D. A.: A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12 (1998) F51-F58.
8. Kerry, I. L. B., Truchis, P., Perronne, C: Hypertrophy of the breasts in a patient treated with indinavir. CID 25 (1997) 937-938.
9. Caslelli, W. P., Anderson, K., Wilson, P. W., Levy, D.: Lipids and risk of coronary heart disease. The Framingham Study. Ann. Epidemiol. 2 (1992) 23-28.
10. Leary, O. D. H., Anderson, K. M., Wolf, P. A., Evans, J. C., Poehlman, H. W.: Cholesterol and carotid atherosclerosis in older persons: the Framingham Study. Ann. Epidemiol. 2 (1992) 147-153.
11. The Scandinavian Simvastatin Survival Study (4S): Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 344 (1994) 1383-1389.
12. Carr, A., Samaras, K., Chisholm, D. J., Cooper, D. A.: Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351 (1998) 1881-1883.